|
Potential SARS-CoV-2 Spike Protein-ACE2 Interface Inhibitors: Repurposing FDA-approved Drugs
Valentina L. Kouznetsova, Aidan Zhang, Mark A. Miller, Mahidhar Tatineni, Jerry P. Greenberg, Igor F. Tsigelny
Published online: December 24, 2021
doi:10.14218/JERP.2021.00050
|